<http://dbpedia.org/resource/Etanercept>	<http://dbpedia.org/ontology/thumbnail>	<http://commons.wikimedia.org/wiki/Special:FilePath/Enbrel.jpg?width=300> .
<http://dbpedia.org/resource/Etanercept>	<http://dbpedia.org/ontology/drugbank>	"DB00005" .
<http://dbpedia.org/resource/Etanercept>	<http://dbpedia.org/ontology/casNumber>	"185243-69-0" .
<http://dbpedia.org/resource/Etanercept>	<http://dbpedia.org/ontology/fdaUniiCode>	"OP401G7OJC" .
<http://dbpedia.org/resource/Etanercept>	<http://dbpedia.org/ontology/atcSuffix>	"AB01" .
<http://dbpedia.org/resource/Etanercept>	<http://dbpedia.org/ontology/bioavailability>	"58.0"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://dbpedia.org/resource/Etanercept>	<http://www.w3.org/2000/01/rdf-schema#comment>	"Etanercept (trade name Enbrel) is a biopharmaceutical that treats autoimmune diseases by interfering with tumor necrosis factor (TNF; a soluble inflammatory cytokine) by acting as a TNF inhibitor. It has U.S. F.D.A. approval to treat rheumatoid arthritis, juvenile rheumatoid arthritis and psoriatic arthritis, plaque psoriasis and ankylosing spondylitis. TNF-alpha is the \"master regulator\" of the inflammatory (immune) response in many organ systems."@en .
<http://dbpedia.org/resource/Etanercept>	<http://xmlns.com/foaf/0.1/depiction>	<http://commons.wikimedia.org/wiki/Special:FilePath/Enbrel.jpg> .
<http://dbpedia.org/resource/Etanercept>	<http://dbpedia.org/ontology/atcPrefix>	"L04" .